Cumberland Pharmaceuticals Inc

Ownership Transactions Reported by 15 Insiders

Symbol
CPIX on Nasdaq
Location
2525 West End Avenue, Suite 950, Nashville,, TN

Insiders trading volume in the past year

Cumberland Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
A. J. Kazimi Chairman and CEO, Director, 10%+ Owner $20.2M +$9.99K +0.05% Sep 2, 2025
Kenneth Krogulski Director $908K +$54K +6.32% Sep 2, 2025
Joseph C. Galante Director $320K Mar 17, 2025
Martin E. Cearnal Sr VP/Chief Commercial Officer, Director $278K Mar 17, 2022
Leo Pavliv SVP and Chief Development Off. $220K May 31, 2022
John Hamm VP Chief Financial Officer $188K Mar 16, 2025
Joey A. Jacobs Director $167K Jan 14, 2023
James L. Herman VP and Chief Compliance Office $165K Mar 17, 2025
James Jones Director $138K +$9.99K +7.81% Sep 2, 2025
Todd M. Anthony Vice Pres Organizational Dev $123K Mar 17, 2025
Caroline Young Director $103K +$4.38K +4.43% Sep 2, 2025
Chris T. Bitterman Vice Pres Sales & Marketing $91.2K Mar 17, 2025
Martin S. Brown JR Director $43.9K Mar 17, 2025
Jonathan Griggs Director $25.2K Mar 17, 2021
Michael Bonner Chief Financial Officer $19.9K Mar 17, 2021

Recent Insider Transactions by Companies or Individuals for Cumberland Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.